Breaking News

Cellares to Establish Commercial Production Site for CAR-T Cell Therapies in Japan

The IDMO Smart Factory will enable scalable and cost-effective cell therapy manufacturing.

Author Image

By: Charlie Sternberg

Associate Editor

Cellares, a pioneer in automated cell therapy manufacturing, is establishing Japan’s first next-gen commercial production site for CAR-T cell therapies. The facility is under construction in Kashiwa City, a booming biotech hub located approximately 30 kilometers northeast of central Tokyo in Chiba Prefecture. This Integrated Development and Manufacturing Organization (IDMO) Smart Factory is expected to provide employment to 350 people while enabling scalable and cost-effective cell therapy ma...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters